is used as a frontline antiplatelet drug in patients with coronary artery
disease, peripheral vascular disease and cerebrovascular disease. Though it is
frequently reported that clopidogrel is associated with thrombotic
thrombocytopenic purpura (TTP), severe isolated thrombocytopenia induced by
this drug is rare. Here we report a case with isolated thrombocytopenia due to
clopidogrel therapy. As this agent is widely used in clinical practice, the
occurrence of this rare but dangerous adverse effect should be considered.
Cite this paper
Zhang, Y. , Zhou, H. and Han, W. (2014) Severe Isolated Thrombocytopenia Associated with the Use of Clopidogrel. Case Reports in Clinical Medicine
, 244-248. doi: 10.4236/crcm.2014.34056
 Balamuthusamy, S. and Arora, R. (2007) Hematologic Adverse Effects of Clopidogrel. American Journal of Therapeutics, 14, 106-112. http://dx.doi.org/10.1097/01.mjt.0000212708.81034.22
 Su, C.H., Tsai, C.F., Ueng, K.C., et al. (2004) Clopidogrel-Associated Severe Isolated Thrombocytopenia—A Case Report. Acta Cardiological Sinica, 20, 182-186.
 Elmi, F., Peacock, T. and Schiavone, J. (2000) Isolated Profound Thrombocytopenia Associated with Clopidogrel. Journal of Invasive Cardiology, 12, 532-535.
 Helft, G., Elalamy, I., Laudy, C., et al. (2003) Clopidogrel and Thrombopenia. A Case Report. Annales de Cardiologie et d’Angéiologie, 52, 191-193. http://dx.doi.org/10.1016/S0003-3928(02)00185-3
 da Silva Vedes, E.C., Marques, L.D.G. and Rico, M.C.T. (2011) Severe Isolated Thrombocytopenia after Clopidogrel and Pentoxifylline Therapy: A Case Report. Journal of Medical Case Reports, 5, 281. http://dx.doi.org/10.1186/1752-1947-5-281
 Drachman, J.G. (2004) Inherited Thrombocytopenia: When a Low Platelet Count Does Not Mean ITP. Blood, 103, 390-398. http://dx.doi.org/10.1182/blood-2003-05-1742
 George, J.N. and Aster, R.H. (2009) Drug-Induced Thrombocytopenia: Pathogenesis, Evaluation, and Management. Hematology American Society of Hematology Education Program, 2009, 153-158. http://dx.doi.org/10.1182/asheducation-2009.1.153
 Scirica, B.M., Cannon, C.P., Cooper, R., et al. (2006) Drug-Induced Thrombocytopenia and Thrombosis: Evidence from Patients Receiving an Oral Glycoprotein IIb/IIIa Inhibitor in the Orbofiban in Patients with Unstable Coronary Syndromes-(OPUS-TIMI 16) Trial. Journal of Thrombosis and Thrombolysis, 22, 95-102.